ICICI Lombard General Insurance Company Ltd (ICICIGI)
🎯 Key Takeaways
- ICICI Lombard General Insurance is in a mature, stable phase with no significant growth momentum visible in recent quarterly financials, which remain blank across all metrics. The company has been consistently issuing new equity shares under its ESOP and ESUS schemes, gradually increasing the total share count and introducing modest dilution risks.
- ⚠️ 1) The absence of disclosed financial results in recent quarters severely limits transparency and makes it impossible to assess profitability, cash ge
📖 The Story
ICICI Lombard General Insurance is in a mature, stable phase with no significant growth momentum visible in recent quarterly financials, which remain blank across all metrics. The company has been consistently issuing new equity shares under its ESOP and ESUS schemes, gradually increasing the total share count and introducing modest dilution risks. While promoter holding remains steady around 51%, there has been a clear trend of declining institutional investor interest, with FII shareholding falling from 24.04% in Q2FY26 to 21.45% in Q1FY27, suggesting possible re-rating or profit booking by foreign investors. The balance sheet shows steady growth in equity and reserves, but without corresponding revenue or profit data to justify the scale, raising questions about capital efficiency.
📰 What's Happening
Over the past few months, ICICI Lombard has executed multiple tranches of share allotments under its ESOP and ESUS schemes, with the most recent being 71,297 shares on August 24, 2026, followed by 13,890 on August 12 and 154,550 on August 4. These issuances are part of pre-approved plans dating back to July 18, 2023, and are primarily directed toward employees and select directors, including a 20,540-share allocation to the Whole-time Director. While these moves reflect ongoing compensation practices, they cumulatively increase the free float and dilute existing shareholders' stakes over time. The consistent pattern suggests management is prioritizing employee retention and long-term incentive structures, but the lack of strategic clarity around capital use raises governance concerns.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating Profit | — | — | — | — |
| OPM % | — | — | — | — |
| Net Profit | — | — | — | — |
| EPS | — | — | — | — |
The company has not disclosed any revenue, operating profit, or net profit figures in the latest quarterly filings, rendering trend analysis impossible through traditional financial lenses. This absence of financial disclosure is particularly notable given the company's scale and sector, especially as peers in the insurance space have reported measurable underwriting and investment income. The lack of transparency in core financials undermines confidence in operational performance and makes it difficult to assess whether the business is under stress, stable, or growing. Without measurable financial outcomes, it is difficult to correlate management's strategic actions with tangible business results.
🔮 Management Outlook & What's Next
There is no publicly available forward guidance or commentary from management regarding future business performance, underwriting targets, or financial expectations in the recent filings. The most recent disclosures focus exclusively on share allotments and board-level authorizations, with no discussion of underwriting results, persistency trends, or investment portfolio strategy. This silence on operational outlook is a red flag, especially in an industry where forward-looking metrics like combined ratio or renewal premium growth are critical. Investors are left without a roadmap for performance expectations.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2026 | Mar 2026 | Mar 2026 | Mar 2027 |
|---|---|---|---|---|
| Equity Capital | 497 | 498 | 498 | 499 |
| Reserves | 15,497 | 16,005 | 16,347 | 16,509 |
| Borrowings | 0 | 0 | 0 | 0 |
| Total Liabilities | 59,281 | 75,848 | — | 79,100 |
| Fixed Assets | 843 | 817 | 751 | 852 |
| Investments | 56,200 | 58,296 | — | 60,579 |
| Total Assets | 59,281 | 75,848 | — | 79,100 |
The balance sheet shows a steady increase in equity and reserves, rising from ₹498 crore in reserves in March 2026 to ₹16,509 crore by March 2027, while total assets have grown to ₹79,100 crore. However, borrowings remain nil, indicating no leverage is being used to fund growth. This suggests that capital accumulation is primarily driven by retained earnings and possibly share issuances rather than strategic investments. The lack of debt is a positive from a solvency perspective, but without corresponding asset growth or revenue generation, the capital base appears to be expanding without clear deployment efficiency.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +2,622 |
| Investing | -1,733 |
| Financing | -336 |
| Net Cash Flow | +554 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 51.4% | 51.3% | 51.3% | 51.2% |
| FII | 24.0% | 23.4% | 22.3% | 21.4% |
| DII | 17.5% | 18.4% | 19.5% | 20.8% |
| Public | 5.5% | 5.5% | 5.4% | 5.2% |
| # Shareholders | 2,39,812 | 2,35,714 | 2,29,930 | 2,29,599 |
Institutional investor holding has declined meaningfully over the past year, with FII ownership dropping from 24.04% in Q2FY26 to 21.45% in Q1FY27, while DII shareholding also fell from 19.52% to 20.75%. Promoter holding remains stable near 51%, but the consistent reduction in foreign investor interest signals waning confidence or reallocation to other financial services stocks. The declining trend in FII and DII stakes, despite stable promoter ownership, suggests that institutional investors may be exiting due to lack of transparency, stagnant financial visibility, or better opportunities elsewhere in the market.
⚖️ Peer Comparison — Insurance
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| LICI | 5.28 L Cr | — | — | — | 0.00 |
| SBILIFE | 1.75 L Cr | — | — | — | 0.00 |
| HDFCLIFE | 1.18 L Cr | — | — | — | 0.00 |
| ICICIGI | 77,881 | — | — | — | 0.00 |
| ICICIPRULI | 74,135 | — | — | — | 0.00 |
| GICRE | 62,246 | — | — | — | 0.00 |
| STARHEALTH | 33,419 | — | — | — | 0.00 |
| NIACL | 31,543 | — | — | — | 0.00 |
| GODIGIT | 23,878 | — | — | — | 0.00 |
| NIVABUPA | 15,023 | — | — | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) The absence of disclosed financial results in recent quarters severely limits transparency and makes it impossible to assess profitability, cash generation, or operational health. 2) Ongoing share dilution through ESOP/ESUS schemes is increasing the total share count without a corresponding strategic justification, potentially eroding shareholder value. 3) Declining FII and DII ownership indicates weakening institutional confidence, which could reduce liquidity and market valuation support. 4) Lack of forward guidance or management commentary on business outlook leaves investors without a basis for forecasting performance or capital allocation plans.
📋 Recent Filings
-
🟡 Board Meeting 24 August 2026ICICI Lombard announced the allotment of 71,297 equity shares of ₹10 each on August 24, 2026 under its ESOP and ESUS schemes, approved by a Whole-time...
-
Announcement 20 August 2026ICICI Lombard announced its September 2026 investor meet schedule, listing five in-person conferences in Mumbai, Gurgaon, and other locations with fun...
-
🟡 Board Meeting 12 August 2026ICICI Lombard announced the allotment of 13,890 equity shares of ₹10 each on August 12, 2026 under its ESOP and ESUS schemes, with 10,151 shares issue...
-
Announcement 12 August 2026ICICI Lombard announced a virtual meeting with Morgan Stanley's India Financials Investor Group on August 28, 2026, after changing the format from in-...
-
Announcement 11 August 2026ICICI Lombard announced it will attend the Motilal Oswal 22nd Annual Global Investor Conference on August 18, 2026, in addition to the previously disc...
-
🟡 Board Meeting 4 August 2026ICICI Lombard announced the allotment of 154,550 equity shares of ₹10 each on August 4, 2026, under its ESOP and ESOS schemes, including 140,126 share...
-
Announcement 3 August 2026ICICI Lombard General Insurance announced its 25th anniversary with the launch of 25 innovative insurance solutions across health, motor, home, travel...
-
Announcement 31 July 2026ICICI Lombard announced a scheduled in-person analyst meeting on August 28, 2026, in Mumbai with Morgan Stanley's India Financials Investor Group, con...
-
Announcement 27 July 2026ICICI Lombard announced its August 2026 schedule of analyst and institutional investor meetings, including in-person conferences with Nirmal Bang, Emk...
-
🟡 Board Meeting 23 July 2026ICICI Lombard announced the allotment of 20,957 equity shares of ₹10 each on July 23, 2026 under the Employees Stock Option Scheme 2005 and Employees ...
🧠 Analyst's Read
The company's narrative is currently defined more by governance and disclosure gaps than by operational momentum or strategic clarity. While the shareholding structure remains stable at the top, the lack of financial transparency and declining institutional interest pose significant concerns. Investors should monitor for future financial disclosures and any shift in management's communication strategy, as these will be critical to reassessing the company's true health and investment potential.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-02.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ICICIGI files new disclosures
Track ICICIGI filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ICICIGI — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd